At today's Annual General Meeting (AGM) of
Presentation and adoption of the accounts and discharge from liability
The AGM noted that the annual report and the auditor's report as well as the consolidated financial statements and the consolidated auditor's report for the financial year 2023 had been duly presented and adopted the income statement and balance sheet as well as the consolidated income statement and consolidated balance sheet. The AGM discharged the members of the Board of Directors and the CEO from liability for the financial year 2023.
Dividend
The AGM resolved in accordance with the Board's proposal that a dividend of
Board of Directors, auditors and fees
The number of directors will be seven with no deputies. The AGM re-elected the Board members
Remuneration to the Board of Directors shall be
Re-election of the registered accounting firm Öhrlings
At the subsequent statutory Board meeting,
Instructions for the Nomination Committee
The AGM resolved to adopt instructions for the appointment of the Nomination Committee and its assignment.
Remuneration report
The AGM resolved to approve the Board' report on remuneration pursuant to Chapter 8, section 53 a § of the Swedish Companies Act for the financial year 2023.
Guidelines for remuneration to senior executives
The AGM resolved on guidelines for remuneration to senior executives in accordance with the Board's proposal.
Authorization for the Board to resolve on new issues of shares
The AGM authorized the Board to, on one or several occasions during the period up until the next AGM with or without deviation from the shareholders' preferential rights, resolve on new issues of shares. The authorization also includes the right to resolve on new issues of shares with terms concerning issues in kind, offset rights or other terms stated in the Swedish Companies Act. Through decision by virtue of the authorization the total number of shares may increase with a number corresponding to maximum ten (10) percent of outstanding shares in the company at the time the Board first uses such authorization. The total number of shares covered by such new issues of shares shall be within the limits of the share capital as stated in the Articles of Association. The purpose of the authorization and the reasons for any deviation from the shareholders' preferential rights according to above, is to ensure financing of acquisitions of companies or businesses or to strengthen the company's capital base and equity ratio. In case of deviation from the shareholders' preferential rights, issues by virtue of the authorization shall be made on market conditions. The Board is also authorized to, subject to the terms above, resolve on other terms that the Board deems necessary to carry out such issues of shares.
The information was submitted for publication, through the agency of the contact persons set out below, at
For more information, please contact:
Phone: +46 70 668 00 15
Email: daniel.ljunggren@mildef.com
Phone: +46 735 41 45 73
Email: olof.engvall@mildef.com
https://news.cision.com/mildef-group-ab/r/annual-general-meeting-of-mildef-group-ab--publ-,c3986155
https://mb.cision.com/Main/20537/3986155/2818430.pdf
https://news.cision.com/mildef-group-ab/i/fortress,c3302980
https://news.cision.com/mildef-group-ab/i/daniel-ljunggren-utanfor-mildef,c3302981
(c) 2024 Cision. All rights reserved., source